Showing results (111-120 of 150) with videos related to
Sort By:
Pageof 15
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumorsTimothy A Yap, Li Yan, Amita Patnaik, et al.Cancer Letters|April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkersHelen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.Journal of Medicinal Chemistry|April 28, 2016
Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70Matthew D Cheeseman, Isaac M Westwood, Olivier Barbeau, et al.BMC Cancer|June 2, 2022
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Lucy Gately, Katharine Drummond, Mark Rosenthal, et al.Molecular Oncology|October 25, 2017
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitorSteven R Whittaker, Clare Barlow, Mathew P Martin, et al.Chemical Science|September 12, 2022
Establishing the selective phospholipid membrane coordination, permeation and lysis properties for a series of 'druggable' supramolecular self-associating antimicrobial amphiphilesJessica E Boles, Charlotte Bennett, Jennifer Baker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid TumorsRobert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, et al.Antimicrobial Agents and Chemotherapy|November 2, 2012
An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacyNeil R Stokes, Nicola Baker, James M Bennett, et al.Eclinicalmedicine|October 7, 2025
The prevalence and risk of mortality associated with antimicrobial resistance within nosocomial settings-a global systematic review and meta-analysis of over 20,000 patientsNisha A George, Daniel Pan, Luisa Silva, et al.Pageof 15